Smiths Industries Appoints New Executive Director
Lawrence Kinet to Take The Helm
LONDON-Lawrence Kinet has been appointed executive director of Smiths Industries plc and will replace George M. Kennedy CBE as head of Smiths Industries Medical Systems when Kennedy retires on August 4, 2000. Kinet earned his BSc at the University of Birmingham, UK, in 1968 and his MBA from the University of Chicago in 1970. From 1973-1988, Kinet held various positions at Baxter International Inc. concluding his career there as Corporate VP & President, World Trade Group. Subsequently he joined The Kensington Group as Managing Partner from 1989-1991 and from 1991-1994 he was the Chairman & CEO of Oculon Corporation. Most recently, Kinet held the position of Chairman, President & CEO of Aksys Ltd from 1994-1999. A US citizen, Kinet will relocate to Smiths Industries headquarters in London.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.
